Relation between the angiotensinogen (AGT) M235T gene polymorphism and blood pressure in a large, homogeneous study population
|
|
- Everett Neal
- 6 years ago
- Views:
Transcription
1 (2003) 17, & 2003 Nature Publishing Group All rights reserved /03 $ ORIGINAL ARTICLE Relation between the angiotensinogen (AGT) M235T gene polymorphism and blood pressure in a large, homogeneous study population JR Ortlepp 1, J Metrikat 2, V Mevissen 1, F Schmitz 1, M Albrecht 2, P Maya-Pelzer 2, P Hanrath 1, K Zerres 3 and R Hoffmann 1 1 Medical Clinic I, University Hospital of Aachen, Pauwelsstrasse 30, Aachen, Germany; 2 German Air Force Institute of Aviation Medicine, Furstenfeldbruck, Germany; 3 Institute of Human Genetics, University Hospital of Aachen, Pauwelsstrasse 30, Aachen, Germany The aim of this study was to assess the association of the angiotensinogen M235T polymorphism with arterial blood pressure (BP) at rest and under physical stress in a homogeneous large-scale study population. In all, 1903 men who passed routine medical examination for military flying duty were recruited. BP and heart rate were measured at rest, during, and after bicycle ergometry. Genotyping for the AGT M235T polymorphism was carried out by PCR and RFLP technique. The AGT T235 allele was associated with a significantly higher diastolic BP (n ¼ 1903; MM , MT , TT ; P ¼ 0.003). Pulse pressure (PP) at rest differed significantly between AGT genotypes (n ¼ 1903; MM mmhg, MT mmhg, TT mmhg; P ¼ 0.001). During physical activity, BP values showed no significant difference between genotypes. In healthy young men, the AGT T235 allele is significantly associated with elevated diastolic BP but also reduced PP at rest. During physical activity, the AGT polymorphism had no impact on blood pressure, indicating the existence of other counteracting mechanisms, which might balance the influence of this gene. (2003) 17, doi: /sj.jhh Keywords: angiotensinogen; AGT; polymorphism; blood pressure; genetics Introduction The regulation of arterial blood pressure (BP) is complex and under the control of different physiological systems. The renin angiotensin aldosterone system (RAAS) is one of the important regulatory systems. Genes encoding products of the RAAS are plausible candidate genes for modifying blood pressure. The angiotensinogen gene (AGT) is one of the few candidates that has been investigated extensively and its genetic variant in exon 2 shows a transition resulting in replacement of methionine by threonine at amino-acid position 235 (M235T). Positive associations between the AGT M235T polymorphism, plasma angiotensinogen levels, and essential arterial hypertension indicate a pathway by which the AGT gene determines arterial BP. 1 5 Correspondence: Dr JR Ortlepp, Medical Clinic I, University Hospital of Aachen, Pauwelsstrasse 30, Aachen 52057, Germany. jrortlepp@ukaachen.de Received 6 February 2003; revised 23 April 2003; accepted 25 April 2003 However, studies in African and Asian populations could not equally support these findings, 6 9 indicating the importance of other genetic factors interfering with the AGT gene. Moreover, the allele frequency of the AGT M235T polymorphism varies strongly within the different ethnic groups. One study found a significant increase in T235 allele frequency in patients with hypertension that was restricted to men, 10 thus gender might also influence the effect of the AGT gene. The diagnosis of essential arterial hypertension is based on BP above a defined cutoff value. However, a recent study indicated that individuals with BP values that have been considered to be at the upper limit of normality already have an increased risk of cardiovascular disease. 11 Thus, arterial hypertension should not be considered as a dichotomous diagnosis of having a BP below or above a certain threshold. Similarly, the same seems to be true for genetic determination of arterial hypertension. Many genes might influence the arterial BP without generating an arterial hypertension. It is the concurrence of multiple factors (gene polymorphisms, gender, age, environ-
2 556 mental conditions), which leads to the manifestation of arterial hypertension. Thus, to study the effect of one gene polymorphism, it might be appropriate to analyse quantitative traits in a homogeneous (homogeneous for: gender, race, occupation, social status, physical fitness, and age) population, rather than categorical traits (like healthy vs arterial hypertension) in heterogeneous populations. The aim of this study was to assess the association of the AGT M235T polymorphism with arterial BP in a large-scale study population of completely healthy young men. Materials and methods Study population The subjects were German male aviators who passed routine medical examination for military flying duties. Physical activity was assessed by standardized questionnaires. Participants were included into the study during routine medical qualification for flying duty. A total of 2000 men were screened and 1903 gave written informed consent (95%) and formed the study population. The study was approved by the local ethical committees. Body mass index Body weight and height were measured between 7 a.m. and 8 a.m. before breakfast, after urination, and undressed, to calculate BMI by division of weight by square of height (kg/m 2 ). Blood pressure and heart rate measurement at rest BP and heart rate (HR) were measured manually by trained personnel after 5 min of rest in supine position in a quiet room between 7 a.m. and 9 a.m. at neutral, ambient temperature. Systolic (SBP), diastolic (DBP), and mean blood pressure (MBP) as well as pulse pressure (PP ¼ SBP DBP) were assessed. DBP was taken as Korotkov V. BP and HR during and after physical exercise, physical fitness (PWC 170) Ergometry was performed in 1750 men. Physical fitness (determined by physical working capacity at an HR of 170 bpm ¼ PWC 170) was assessed by standard cycle ergometry in 451 sitting position and expressed as the achieved performance (watts (W)) per kilogram of body weight (kg) at an actual HR of 170 bpm. Ergometric power was increased every 3 min by steps of 50 W, starting from 100 W up to the point of physical exhaustion or commonly accepted termination criteria. Ergometric performance was monitored by continuous ECG, supervised by an experienced physician. HR, SBP, DBP, MBP, and PP were assessed 3 min, and 6 min during ergometry and 3 min after ergometry. At 3 min ergometry corresponds to 3 min 100 W, 6 min ergometry corresponds to 3 min 100 W plus 3 min 150 W. Genotyping Genomic DNA of patients was extracted from whole blood using the InVitek Blood Kit (InVitek, Berlin, Germany). The AGT M235T polymorphism was tested as described previously. 1 Statistical analysis Continuous data are presented as mean 7 s.d. and categorical data are presented as frequencies. Differences in BP were calculated by ANOVA. A linear regression analysis was performed to evaluate the impact of AGT on pulse pressure. A multivariable analysis was performed including BMI, age, and AGT genotype. Significant differences were defined Table 1 Characteristics of the study population N 1903 Age (year) Height (cm) Weight (cm) BMI (kg/m 2 ) SBP at rest (mmhg) DBP at rest (mmhg) MBP at rest (mmhg) PP at rest (mmhg) HR at rest (bpm) Physical activity (h/week) Physical fitness PWC170 (W/kg) SBP at 3 min ergometry (mmhg) DBP at 3 min ergometry (mmhg) MBP at 3 min ergometry (mmhg) PP at 3 min ergometry (mmhg) HR at 3 min ergometry (bpm) SBP at 6 min ergometry (mmhg) DBP at 6 min ergometry (mmhg) MBP at 6 min ergometry (mmhg) PP at 6 min ergometry (mmhg) HR at 6 min ergometry (bpm) SBP 3 min after ergometry (mmhg) DBP 3 min after ergometry (mmhg) MBP 3 min after ergometry (mmhg) PP 3 min after ergometry (mmhg) HR 3 min after ergometry (bpm) Physical fitness (determined by physical working capacity at an HR of 170 bpm=pwc170) was assessed by standard cycle ergometry in 451 sitting position and expressed as the achieved performance (watt (W) per kilogram of body weight (kg) at an actual HR of 170 bpm). Ergometric power was increased every 3 min by steps of 50 W, starting from 100 W up to the point of physical exhaustion or commonly accepted termination criteria. A 3 min ergometry corresponds to 3 min of 100 W, 6 min ergometry corresponds to 3 min of 100 W plus 3 min of 150 W; ergometry was performed in 1750 men. SBP=systolic blood pressure; DBP=diastolic blood pressure, MBP=mean blood pressure; PP=pulse pressure, HR=heart rate, PWC 170=physical working capacity at a heart rate of 170 bpm.
3 as a two-sided P-valueo0.05. Statistical figures show mean values with 95% confidence interval. All calculations were performed with SPSS for Windows s The null hypothesis was that men with different AGT genotypes do not have different BP values. Results Phenotypes The characteristics of the study population are given in Table 1. The study population represents a hyperhealthy population with few obese men and high physical activity and fitness. Genotypes The frequencies of the AGT M235T genotypes and alleles are shown in Table 2. Table 2 Genotype and allele frequencies of the angiotensinogen AGT M235T polymorphism AGT 235 genotype MM (n(%)) 627 (32.9%) TM (n(%)) 1039 (54.6%) TT (n(%)) 237 (12.5%) AGT 235 allele frequency M T Relation of AGT genotype and BP values As given in Table 3, the AGT genotypes were associated with different DBP and PP at rest. Men homozygous for the T allele had the lowest PP at rest. These findings are further illustrated in Figure 1. During and after physical activity BP values did not differ between the AGT genotypes (Table 3). Multivariable analysis In a multivariable analysis for DBP and PP including age, BMI, and AGT genotype, all variables were significantly associated with DBP (age: F ¼ , Po0.001; BMI: F ¼ 9.535, P ¼ 0.002; AGT genotype: F ¼ 5.390, P ¼ 0.005) and PP (age: F ¼ , Po0.001; BMI: F ¼ , Po0.001; AGT genotype: F ¼ 8.012, Po0.001). Discussion The impact of the angiotensinogen gene (AGT) M235T polymorphism on plasma angiotensinogen levels and essential arterial hypertension has been reported. 1 5 However, the finding of an association could not be repeated in all subsequent studies. 6 9 A recent study found a significant impact of the AGT genotype on arterial blood pressure during exercise in 190 men, participating in the HERITAGE family study. 12 However, the impact of the AGT M235T polymorphism on the regulation of arterial blood 557 SBP mean with 95 %CI [mmhg] MBP mean with 95 %CI [mmhg] P=0.486 P=0.323 DBP mean with 95 %CI [mmhg] PP mean with 95 %CI [mmhg] P=0.003 P=0.001 Figure 1 Relation of the AGT M235T genotype with SBP, DBP, MBP, and PP at rest in a study population of 1903 young male active aviators of the German Armed Forces. SBP ¼ systolic blood pressure; DBP ¼ diastolic blood pressure, MBP ¼ mean blood pressure; PP ¼ pulse pressure.
4 558 Table 3 Relation of AGT genotype anthropomorphic parameters and blood pressure values at rest, during, and after exercise AGT 235 MM TM TT P N Age (year) BMI (kg/m 2 ) SBP at rest (mmhg) DBP at rest (mmhg) MBP at rest (mmhg) PP at rest (mmhg) HR at rest (bpm) Physical activity (h/week) Physical fitness PWC170 (W/kg) SBP at 3 min ergometry (mmhg) DBP at 3 min ergometry (mmhg) MBP at 3 min ergometry (mmhg) PP at 3 min ergometry (mmhg) HR at 3 min ergometry (bpm) SBP at 6 min ergometry (mmhg) DBP at 6 min ergometry (mmhg) MBP at 6 min ergometry (mmhg) PP at 6 min ergometry (mmhg) HR at 6 min ergometry (bpm) SBP 3 min after ergometry (mmhg) DBP 3 min after ergometry (mmhg) MBP 3 min after ergometry (mmhg) PP 3 min after ergometry (mmhg) HR 3 min after ergometry (bpm) Physical fitness (determined by physical working capacity at an HR of 170 bpm=pwc170) was assessed by standard cycle ergometry in 451 sitting position and expressed as the achieved performance (watt (W) per kilogram of body weight (kg) at an actual HR of 170 bpm). Ergometric power was increased every 3 min by steps of 50 W, starting from 100 W up to the point of physical exhaustion or commonly accepted termination criteria. A 3 min ergometry corresponds to 3 min of 100 W, 6 min ergometry corresponds to 3 min of 100 W plus 3 min of 150 W; ergometry was performed in 1750 men. SBP=systolic blood pressure; DBP=diastolic blood pressure, MBP=mean blood pressure; PP=pulse pressure, HR=heart rate, PWC 170=physical working capacity at a heart rate of 170 bpm. pressure remains incompletely defined. This study evaluated the relation of the AGT genotype to arterial BP in almost 2000 male active aviators of the German Armed Forces. The major findings of this study are that the AGT M235T gene polymorphism is significantly associated with increased DBP and reduced PP in men at a relatively young age, whereas SBP did not differ significantly between the AGT genotypes. Even when the F-value for the AGT genotype in the multivariable analysis for blood pressure is low, the effect of the AGT genotype on BP regulation is detectable in a period of life far before the general incidence of arterial hypertension. During physical stress, the influence of the AGT gene polymorphism on blood pressure regulation could not be detected. Other additional yet unknown genetic or nongenetic factors could influence this genotype phenotype relation. We speculate that individuals with the T allele might be more prone to cardiovascular diseases later in life, because of the elevation of DBP very early in life. The effect of reduced PP in this young population remains uncertain. Moreover, a difference in the DBP of 2 mmhg might also have only minor relevance. Owing to the relatively small extent of the effect of the AGT genotype polymorphisms of other genes might be associated with BP regulation. In addition, multiple other polymorphisms within the AGT gene have been described and the combination of these multiple AGT polymorphisms might have a higher influence on BP regulation than just a single polymorphism. Further large studies should therefore investigate the haplotype analysis of several candidate genes of the RAAS. The strength of this study is the number of included subjects and the homogeneity of the examined population. In this study population, all subjects had the same gender, race and nationality, similar age, physical fitness, occupation, annual income, social status, and their principal meals were provided by the military five days a week. Thus, this population was controlled for more exogenic factors than it would be possible for patient or population selected study populations. The limitation of this study is that this cohort is not representative of a regular population. For example, we cannot predict the effect of the AGT gene on blood pressure of females, old men, or
5 classical hypertensives. Furthermore, because of the cross-sectional character of this study, we cannot prove that gene carriers with relatively high BP will develop cardiovascular disease years or decades later. However, even if the examined military pilots do not match a regular population, they are in particular suitable to serve as an example for genetic environmental interactions because of their highly homogeneous population characteristics. In summary, we conclude that the effect of the AGT M235T gene polymorphism on blood pressure regulation, even to a small extent, is detectable very early in life, far before the onset of arterial hypertension. Acknowledgement This study was supported by the START program of the University Hospital of Aachen. The work resulting in this report was performed under German Federal Ministry of Defense Contract 21L2-S The opinions expressed in this paper are those of the authors and do not necessarily reflect the opinions or official policy of the German Federal Ministry of Defense. We gratefully acknowledge the support of the medical assistants of Dep. I and the backing of Dep. III of the German Air Force Institute of Aviation Medicine. JR Ortlepp designed the study, did statistical data analysis, J Metrikat coordinated and realized data collection, M Albrecht and P Maya-Pelzer helped with data collection, V Mevissen, F Schmitz, and K Zerres fulfilled genetic analysis, P Hanrath, K Zerres, and R Hoffmann took part in interpretation of data and critical revision. All authors helped to write the report. This work is part of the doctoral thesis of JM Conflict of Interest Statement: None declared. References 1 Jeunemaitre X et al. Molecular basis of human hypertension: role of angiotensinogen. Cell 1992; 71: Caulfield M et al. Linkage of the angiotensinogen gene to essential hypertension. N Engl J Med 1994; 330: Tiret L et al. Genetic variation at the angiotensinogen locus in relation to high blood pressure and myocardial infarction: the ECTIM Study. J Hypertens 1995; 13: Schunkert H et al. The angiotensinogen T235 variant and the use of antihypertensive drugs in a populationbased cohort. Hypertension 1997; 29: Kunz R et al. Association between the angiotensinogen 235T-variant and essential hypertension in whites: a systematic review and methodological appraisal. Hypertension 1997; 30: Rotimi C et al. Hypertension, serum angiotensinogen, and molecular variants of the angiotensinogen gene among Nigerians. Circulation 1997; 95: Niu T et al. Angiotensinogen gene and hypertension in Chinese. J Clin Invest 1998; 101: Hingorami AD et al. Blood pressure and the M235T polymorphism of the angiotensinogen gene. Hypertension 1996; 28: Brand E et al. Evaluation of the angiotensinogen locus in human essential hypertension: a European study. Hypertension 1998; 31: Tiret L et al. Gene polymorphisms of the renin angiotensin system in relation to hypertension and parental history of myocardial infarction and stroke: the PEGASE study. Projet d Etude des Gene de l Hypertension Arterielle Severe a moderee Essentielle. J Hypertens 1998; 16: Vasan RS et al. Impact of high-normal blood pressure on the risk of cardiovascular disease. New Engl J Med 2001; 345: Rankinen T et al. AGT M235T and ACE ID polymorphisms and exercise blood pressure in the HERITAGE Family Study. Am J Physiol Heart Circ Physiol 2000; 279: H368 H
Treatment A Placebo to match COREG CR 20 mg OD + Lisinopril 10 mg OD (Days 1-7) Placebo to match COREG CR 40 mg OD + Lisinopril 10 mg OD (Days 8-14)
The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.
More informationUniversity of Padova, Padua, Italy, and HARVEST Study Group, Italy
University of Padova, Padua, Italy, and HARVEST Study Group, Italy ISOLATED SYSTOLIC HYPERTENSION IN THE YOUNG DOES NOT IMPLY AN INCREASED RISK OF FUTURE HYPERTENSION NEEDING TREATMENT Mos L, Saladini
More informationPREVALENCE OF HYPERTENSION AND ITS ASSOCIATED RISK FACTORS AMONG SCHOOL AGE CHILDREN
PREVALENCE OF HYPERTENSION AND ITS ASSOCIATED RISK FACTORS AMONG SCHOOL AGE CHILDREN DR.AZAD ABDUL JABAR HALEEM AL-MEZORI- Dohuk Medical school/ University of Duhok-Kurdistan- Iraq Prof. Dr. AbbasAl-Rabaty-HawlerMedical
More informationAssociation between G-217A polymorphism in the AGT gene and essential hypertension: a meta-analysis
Association between G-217A polymorphism in the AGT gene and essential hypertension: a meta-analysis R. Yao*, Y.Y. Du*, Y.Z. Zhang, Q.H. Chen, L.S. Zhao and L. Li Department of Cardiology, the First Affiliated
More informationPositive association of CYP11B2 gene polymorphism with genetic predisposition
(2002) 16, 789 793 & 2002 Nature Publishing Group All rights reserved 0950-9240/02 $25.00 www.nature.com/jhh ORIGINAL ARTICLE Positive association of CYP11B2 gene polymorphism with genetic predisposition
More informationClinical Studies 129
Clinical Studies 129 Syncope in migraine. The population-based CAMERA study Roland D. Thijs, 1* Mark C. Kruit, 2* Mark A. van Buchem, 2 Michel D. Ferrari, 1 Lenore J. Launer, 3,4 and J. Gert van Dijk
More informationAssociation between the CYP11B2 gene 344T>C polymorphism and coronary artery disease: a meta-analysis
Association between the CYP11B2 gene 344T>C polymorphism and coronary artery disease: a meta-analysis Y. Liu, H.L. Liu, W. Han, S.J. Yu and J. Zhang Department of Cardiology, The General Hospital of the
More informationSYNOPSIS. Publications No publications at the time of writing this report.
Drug product: TOPROL-XL Drug substance(s): Metoprolol succinate Study code: D4020C00033 (307A) Date: 8 February 2006 SYNOPSIS Dose Ranging, Safety and Tolerability of TOPROL-XL (metoprolol succinate) Extended-release
More informationBlood Pressure Measurement in SPRINT
Blood Pressure Measurement in SPRINT Karen C. Johnson, MD, MPH, FAHA Vice Chair, SPRINT Steering Committee University of Tennessee Health Science Center, Department of Preventive Medicine For the SPRINT
More informationLow fractional diastolic pressure in the ascending aorta increased the risk of coronary heart disease
(2002) 16, 837 841 & 2002 Nature Publishing Group All rights reserved 0950-9240/02 $25.00 www.nature.com/jhh ORIGINAL ARTICLE Low fractional diastolic pressure in the ascending aorta increased the risk
More information1. Department of Gynecology and Obstetrics, St. Joseph's Hospital Berlin Tempelhof, Germany
Page 1 of 9 Validation of the TONOPORT VI ambulatory blood pressure monitor, according to the European Society of Hypertension International Protocol revision 2010 Michael Abou-Dakn 1, Cornelius Döhmen
More informationYuqing Zhang, M.D., FESC Department of Cardiology, Fu Wai Hospital. CAMS & PUMC, Beijing, China
What Can We Learn from the Observational Studies and Clinical Trials of Prehypertension? Yuqing Zhang, M.D., FESC Department of Cardiology, Fu Wai Hospital. CAMS & PUMC, Beijing, China At ARIC visit 4
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Wanner C, Inzucchi SE, Lachin JM, et al. Empagliflozin and
More informationSlide notes: This presentation highlights the issues involved in preventing hypertension. Slide notes are included for the majority of slides,
3/23/2016 1 This presentation highlights the issues involved in preventing hypertension. Slide notes are included for the majority of slides, containing source materials and references. 2 The Framingham,
More informationValidation of the SEJOY BP-1307 upper arm blood pressure monitor for home. blood pressure monitoring according to the European Society of Hypertension
Validation of the SEJOY BP-1307 upper arm blood pressure monitor for home blood pressure monitoring according to the European Society of Hypertension International Protocol revision 2010 Short title: Validation
More informationEndothelial function is impaired in women who had pre-eclampsia
Endothelial function is impaired in women who had pre-eclampsia Christian Delles, Catriona E Brown, Joanne Flynn, David M Carty Institute of Cardiovascular and Medical Sciences University of Glasgow United
More informationClinical Study Synopsis for Public Disclosure
abcd Clinical Study Synopsis for Public Disclosure This clinical study synopsis is provided in line with s Policy on Transparency and Publication of Clinical Study Data. The synopsis - which is part of
More informationNormal blood pressure values as perceived by normotensive and hypertensive subjects
ORIGINAL ARTICLE Normal blood pressure values as perceived by normotensive and hypertensive subjects (2003) 17, 87 91 & 2003 Nature Publishing Group All rights reserved 0950-9240/03 $25.00 www.nature.com/jhh
More informationHigh-dose monotherapy vs low-dose combination therapy of calcium channel blockers and angiotensin receptor blockers in mild to moderate hypertension
(2005) 19, 491 496 & 2005 Nature Publishing Group All rights reserved 0950-9240/05 $30.00 www.nature.com/jhh ORIGINAL ARTICLE High-dose monotherapy vs low-dose combination therapy of calcium channel blockers
More informationSupplementary Online Content
Supplementary Online Content Pedersen SB, Langsted A, Nordestgaard BG. Nonfasting mild-to-moderate hypertriglyceridemia and risk of acute pancreatitis. JAMA Intern Med. Published online November 7, 2016.
More informationJNC Evidence-Based Guidelines for the Management of High Blood Pressure in Adults
JNC 8 2014 Evidence-Based Guidelines for the Management of High Blood Pressure in Adults Table of Contents Why Do We Treat Hypertension? Blood Pressure Treatment Goals Initial Therapy Strength of Recommendation
More informationIndividual Study Table Referring to Item of the Submission: Volume: Page:
2.0 Synopsis Name of Company: Abbott Laboratories Name of Study Drug: Meridia Name of Active Ingredient: Sibutramine hydrochloride monohydrate Individual Study Table Referring to Item of the Submission:
More informationTheoretical and practical questions in the evaluation of arterial function Miklós Illyés MD. Ph.D.
Theoretical and practical questions in the evaluation of arterial function Miklós Illyés MD. Ph.D. TensioMed Arterial Stiffness Centre, Budapest Heart Institute, Faculty of Medicine, University of Pécs
More informationEstrogens vs Testosterone for cardiovascular health and longevity
Estrogens vs Testosterone for cardiovascular health and longevity Panagiota Pietri, MD, PhD, FESC Director of Hypertension Unit Athens Medical Center Athens, Greece Women vs Men Is there a difference in
More informationARIC Manuscript Proposal # PC Reviewed: 2/10/09 Status: A Priority: 2 SC Reviewed: Status: Priority:
ARIC Manuscript Proposal # 1475 PC Reviewed: 2/10/09 Status: A Priority: 2 SC Reviewed: Status: Priority: 1.a. Full Title: Hypertension, left ventricular hypertrophy, and risk of incident hospitalized
More informationThe effect of a change in ambient temperature on blood pressure in normotensives
(2001) 15, 113 117 2001 Nature Publishing Group All rights reserved 0950-9240/01 $15.00 www.nature.com/jhh ORIGINAL ARTICLE The effect of a change in ambient temperature on blood pressure in normotensives
More informationThe Hypertension Clinic is a part of the Internal Medicine
Original Article Hypertension Registry at the Bangkok Hospital Medical Center: The First 7 Months Experience OBJECTIVE: The Hypertension Registry at the Bangkok Hospital Medical Center was established
More informationChapter Two Renal function measures in the adolescent NHANES population
0 Chapter Two Renal function measures in the adolescent NHANES population In youth acquire that which may restore the damage of old age; and if you are mindful that old age has wisdom for its food, you
More informationINCREASED PULSE PRESSURE AND SYSTOLIC x HEART RATE DOUBLE PRODUCT AND CARDIOVASCULAR AUTONOMIC NEUROPATHY IN TYPE 2 DIABETIC PATIENTS
INCREASED PULSE PRESSURE AND SYSTOLIC x HEART RATE DOUBLE PRODUCT AND CARDIOVASCULAR AUTONOMIC NEUROPATHY IN TYPE 2 DIABETIC PATIENTS A.J. Scheen, J.C. Philips, M. Marchand Division of Diabetes, Nutrition
More informationHypertension Update Warwick Jaffe Interventional Cardiologist Ascot Hospital
Hypertension Update 2008 Warwick Jaffe Interventional Cardiologist Ascot Hospital Definition of Hypertension Continuous variable At some point the risk becomes high enough to justify treatment Treatment
More informationPFIZER INC. THERAPEUTIC AREA AND FDA APPROVED INDICATIONS: See USPI.
PFIZER INC. These results are supplied for informational purposes only. Prescribing decisions should be made based on the approved package insert. For publications based on this study, see associated bibliography.
More informationKnow Your Number Aggregate Report Comparison Analysis Between Baseline & Follow-up
Know Your Number Aggregate Report Comparison Analysis Between Baseline & Follow-up... Study Population: 340... Total Population: 500... Time Window of Baseline: 09/01/13 to 12/20/13... Time Window of Follow-up:
More informationCentral pressures and prediction of cardiovascular events in erectile dysfunction patients
Central pressures and prediction of cardiovascular events in erectile dysfunction patients N. Ioakeimidis, K. Rokkas, A. Angelis, Z. Kratiras, M. Abdelrasoul, C. Georgakopoulos, D. Terentes-Printzios,
More informationOriginal Research Article
A STUDY TO ESTIMATE SUBCLINICAL ATHEROSCLEROSIS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS BY MEASURING THE CAROTID INTIMAL MEDIAL THICKNESS Natarajan Kandasamy 1, Rajan Ganesan 2, Thilakavathi Rajendiran
More informationClinical Significance of Aldosterone Levels and Low Grade Inflammation in Patients with Coronary Vasospasm
Clinical Significance of Aldosterone Levels and Low Grade Inflammation in Patients with Coronary Vasospasm Department of Cardiology Keiji Inoue Akira Ueoka, Naoki Maruyama, Yoshiaki Shimoda, Eigo Kishita,
More informationCONTENT SUPPLEMENTARY FIGURE E. INSTRUMENTAL VARIABLE ANALYSIS USING DESEASONALISED PLASMA 25-HYDROXYVITAMIN D. 7
CONTENT FIGURES 3 SUPPLEMENTARY FIGURE A. NUMBER OF PARTICIPANTS AND EVENTS IN THE OBSERVATIONAL AND GENETIC ANALYSES. 3 SUPPLEMENTARY FIGURE B. FLOWCHART SHOWING THE SELECTION PROCESS FOR DETERMINING
More informationPrognostic significance of blood pressure measured in the office, at home and during ambulatory monitoring in older patients in general practice
(2005) 19, 801 807 & 2005 Nature Publishing Group All rights reserved 0950-9240/05 $30.00 www.nature.com/jhh ORIGINAL ARTICLE Prognostic significance of blood pressure measured in the office, at home and
More informationA fixed-dose combination of bisoprolol and amlodipine in daily practice treatment of hypertension: Results of a noninvestigational
Hostalek U et al. Medical Research Archives, vol. 5, issue 11, November 2017 issue Page 1 of 11 RESEARCH ARTICLE A fixed-dose combination of bisoprolol and amlodipine in daily practice treatment of hypertension:
More informationRetrospective Cohort Study for the Evaluation of Life- Style Risk Factors in Developing Metabolic Syndrome under the Estimated Abdominal Circumference
Original Asian Pacific Journal of Disease Management 2007; 1(2), 55-63 Retrospective Cohort Study for the Evaluation of Life- Style Risk Factors in Developing Metabolic Syndrome under the Estimated Abdominal
More informationAssociation of Arg16Gly Polymorphism of the Beta-2 Adrenergic receptor with Baroreflex Sensitivity and Indices of Autonomic Cardiovascular Modulation
Association of Arg16Gly Polymorphism of the Beta-2 Adrenergic receptor with Baroreflex Sensitivity and Indices of Autonomic Cardiovascular Modulation Ochoa JE 1,2, Correa M 1,5, Gallo J 3,5, McEwen J 1,3,
More informationEXPERIMENTAL and MOLECULAR MEDICINE, Vol. 35, No. 6, , December 2003
EXPERIMENTAL and MOLECULAR MEDICINE, Vol. 35, No. 6, 545-549, December 2003 Angiotensin converting enzyme I/D, angiotensinogen T174M-M235T and angiotensin II type 1 receptor A1166C gene polymorphisms in
More informationClinical Study Synopsis
Clinical Study Synopsis This Clinical Study Synopsis is provided for patients and healthcare professionals to increase the transparency of Bayer's clinical research. This document is not intended to replace
More informationEffects of Renin-Angiotensin System blockade on arterial stiffness and function. Gérard M. LONDON Manhès Hospital Paris, France
Effects of Renin-Angiotensin System blockade on arterial stiffness and function Gérard M. LONDON Manhès Hospital Paris, France Determinants of vascular overload (afterload) on the heart Peripheral Resistance
More informationDysglycaemia and Hypertension. Dr E M Manuthu Physician Kitale
Dysglycaemia and Hypertension Dr E M Manuthu Physician Kitale None Disclosures DM is MI equivalent MR FIT Objective was to assess predictors of CVD mortality among men with and without diabetes and
More informationPrevalence, awareness, treatment and control of hypertension in employees of factories of Northern Greece: the Naoussa study
(2004) 18, 623 629 & 2004 Nature Publishing Group All rights reserved 0950-9240/04 $30.00 www.nature.com/jhh ORIGINAL ARTICLE Prevalence, awareness, treatment and control of hypertension in employees of
More informationCover Page. The handle holds various files of this Leiden University dissertation.
Cover Page The handle http://hdl.handle.net/1887/35456 holds various files of this Leiden University dissertation. Author: Hassan, Suha Mustafa Title: Toward prevention of Hemoglobinopathies in Oman Issue
More informationValue of cardiac rehabilitation Prof. Dr. L Vanhees
Session: At the interface of hypertension and coronary heart disease haemodynamics, heart and hypertension Value of cardiac rehabilitation Prof. Dr. L Vanhees ESC Stockholm August 2010 Introduction There
More informationUsing the New Hypertension Guidelines
Using the New Hypertension Guidelines Kamal Henderson, MD Department of Cardiology, Preventive Medicine, University of North Carolina School of Medicine Kotchen TA. Historical trends and milestones in
More informationNephropathy in Type 1 Diabetes: Can One Identity the Patients at Risk?
Nephropathy in Type 1 Diabetes: Can One Identity the Patients at Risk? Pierre Lefèbvre University of Liège, Belgium Cuba, November 2007 Nephropathy in Type 1 Diabetes It has been known for years that the
More informationa Centre d Investigations Préventives et Cliniques, b Hypertension and Received 18 July 2007 Revised 11 February 2008 Accepted 13 February 2008
1072 Original article Cardiovascular risk as defined in the 2003 European blood pressure classification: the assessment of an additional predictive value of pulse pressure on mortality Frédérique Thomas
More informationStopping oral contraceptives: an effective blood pressure-lowering intervention in women with hypertension
(2005) 19, 451 455 & 2005 Nature Publishing Group All rights reserved 0950-9240/05 $30.00 www.nature.com/jhh ORIGINAL ARTICLE Stopping oral contraceptives: an effective blood pressure-lowering intervention
More informationHypertension and obesity. Dr Wilson Sugut Moi teaching and referral hospital
Hypertension and obesity Dr Wilson Sugut Moi teaching and referral hospital No conflict of interests to declare Obesity Definition: excessive weight that may impair health BMI Categories Underweight BMI
More informationThe hypertensive effects of the renin-angiotensin
Comparison of Telmisartan vs. Valsartan in the Treatment of Mild to Moderate Hypertension Using Ambulatory Blood Pressure Monitoring George Bakris, MD A prospective, randomized, open-label, blinded end-point
More informationVerapamil SR and trandolapril combination therapy in hypertension a clinical trial of factorial design
Br J Clin Pharmacol 1998; 45: 491 495 Verapamil SR and trandolapril combination therapy in hypertension a clinical trial of factorial design Juergen Scholze, 1 Peter Zilles 2 & Daniele Compagnone 2 on
More informationBlood pressure and total cholesterol level are critical risks especially for hemorrhagic stroke in Akita, Japan.
Blood pressure and total cholesterol level are critical risks especially for hemorrhagic stroke in Akita, Japan. Manabu Izumi, Kazuo Suzuki, Tetsuya Sakamoto and Masato Hayashi Jichi Medical University
More informationSpecial Lecture 11/08/2013. Hypertension Dr. HN Mayrovitz
Special Lecture 11/08/2013 Hypertension Dr. HN Mayrovitz Arterial Blood Pressure (ABP) Major Factors Summarized Sympathetic Hormones Arteriole MAP ~ Q x TPR + f (V / C) SV x HR Renal SBP Hypertension =
More informationThe German National Cohort (GNC)
The German National Cohort (GNC) 19.11.2015 1 Aims of the German National Cohort To address research questions concerning a wide range of possible causes for major chronic diseases Extensive collection
More informationSUPPLEMENTARY DATA. Supplementary Table 1. Baseline Patient Characteristics
Supplementary Table 1. Baseline Patient Characteristics Normally distributed data are presented as mean (±SD), data that were not of a normal distribution are presented as median (ICR). The baseline characteristics
More informationDepok-Indonesia STEPS Survey 2003
The STEPS survey of chronic disease risk factors in Indonesia/Depok was carried out from February 2003 to March 2003. Indonesia/Depok carried out Step 1, Step 2 and Step 3. Socio demographic and behavioural
More informationDETERMINANTS OF DAY-NIGHT DIFFERENCE IN BLOOD PRESSURE IN SUBJECTS OF AFRICAN ANCESTRY
i DETERMINANTS OF DAY-NIGHT DIFFERENCE IN BLOOD PRESSURE IN SUBJECTS OF AFRICAN ANCESTRY Joseph Muzi Maseko A dissertation submitted to the Faculty of Health Sciences, University of the Witwatersrand,
More informationT. Suithichaiyakul Cardiomed Chula
T. Suithichaiyakul Cardiomed Chula The cardiovascular (CV) continuum: role of risk factors Endothelial Dysfunction Atherosclerosis and left ventricular hypertrophy Myocardial infarction & stroke Endothelial
More informationSection 03: Pre Exercise Evaluations and Risk Factor Assessment
Section 03: Pre Exercise Evaluations and Risk Factor Assessment ACSM Guidelines: Chapter 3 Pre Exercise Evaluations ACSM Manual: Chapter 3 Risk Factor Assessments HPHE 4450 Dr. Cheatham Purpose The extent
More informationInfluence of Age, Hypertension or Myocardial Infarction on Cardiovascular Responses to Changes in Body Position
Influence of Age, Hypertension or Myocardial Infarction on Cardiovascular Responses to Changes in Body Position A population-based study in 30-, 50- and 60-year-old men BY ANNA HOFSTEN UPPSALA UNIVERSITY
More informationPrevention of Atrial Fibrillation and Heart Failure in the Hypertensive Patient
Prevention of Atrial Fibrillation and Heart Failure in the Hypertensive Patient The Issue of Primary Prevention of A.Fib. (and Heart Failure) and not the Prevention of Recurrent A.Fib. after Electroconversion
More informationThis Protocol is applicable to Class 1, 2, and Class 3 applicants. Resting ECG shall be performed at the following intervals:
SCHEDULE 34: PROTOCOL ON ELECTROCARDIOGRAMS ( ECG ) 1. Applicability This Protocol is applicable to Class 1, 2, and Class 3 applicants. 2. Resting ECG Resting ECG shall be perfmed at the following intervals:
More informationTodd S. Perlstein, MD FIFTH ANNUAL SYMPOSIUM
Todd S. Perlstein, MD FIFTH ANNUAL SYMPOSIUM Faculty Disclosure I have no financial interest to disclose No off-label use of medications will be discussed FIFTH ANNUAL SYMPOSIUM Recognize changes between
More informationAssociation between interleukin-17a polymorphism and coronary artery disease susceptibility in the Chinese Han population
Association between interleukin-17a polymorphism and coronary artery disease susceptibility in the Chinese Han population G.B. Su, X.L. Guo, X.C. Liu, Q.T. Cui and C.Y. Zhou Department of Cardiothoracic
More informationLong-term Blood Pressure Variability throughout Young Adulthood and Cognitive Function in Midlife; CARDIA study
The EPI/NPAM Spring 2014 Scientific Sessions, Hilton San Francisco Union Square, San Francisco, CA Northwestern Mar. 18-21, 2014 University Feinberg School of Medicine Long-term Blood Pressure Variability
More informationBlood Pressure Targets in Diabetes
Stockholm, 29 th August 2010 ESC Meeting Blood Pressure Targets in Diabetes Peter M Nilsson, MD, PhD Department of Clinical Sciences University Hospital, Malmö Sweden Studies on BP in DM2 ADVANCE RCT (Lancet
More informationVol. 43, No. 1, September 1997 BIOCHEMISTRY ond MOLECULAR BIOLOGY INTERNATIONAL Pages
Vol. 43, No. 1, September 1997 BIOCHEMISTRY ond MOLECULAR BIOLOGY INTERNATIONAL Pages 227-231 ANGIOTENSIN II TYPE I RECEPTOR POLYMORPHISM IN AFRICAN AMERICANS LOWER FREQUENCY OF THE C n66 VARIANT Short
More informationJared Moore, MD, FACP
Hypertension 101 Jared Moore, MD, FACP Assistant Program Director, Internal Medicine Residency Clinical Assistant Professor of Internal Medicine Division of General Medicine The Ohio State University Wexner
More informationPrevalence, awareness of hypertension in rural areas of Kurnool
Original article: Prevalence, awareness of hypertension in rural areas of Kurnool Dr. Sudhakar Babu*, Dr.Aruna MS** *Associate Professor, Dept of Community Medicine, Vishwa Bharathi Medical College Kurnool,
More informationAlexandra Meynier Jan de Vries On behalf of Healthgrain Forum, task force Health Benefits
Factors influencing the outcome of human intervention trials A case study using studies examing the effects of whole grain consumption on blood pressure in humans Alexandra Meynier Jan de Vries On behalf
More informationEFFECT OF PLANT SOURCE DIETARY INTAKE ON BLOOD PRESSURE OF ADULTS IN BAYELSA STATE
EFFECT OF PLANT SOURCE DIETARY INTAKE ON BLOOD PRESSURE OF ADULTS IN BAYELSA STATE 1 Dr. Olusegun, A. Kuforiji & 2 John Samuel 1 Department of Agricultural Technology, Federal Polytechnic, Ekowe, Bayelsa
More informationEffects of exercise, diet and their combination on blood pressure
(2005) 19, S20 S24 & 2005 Nature Publishing Group All rights reserved 0950-9240/05 $30.00 www.nature.com/jhh ORIGINAL ARTICLE Effects of exercise, diet and their combination on blood pressure Department
More informationCHAPTER 3 DIABETES MELLITUS, OBESITY, HYPERTENSION AND DYSLIPIDEMIA IN ADULT CENTRAL KERALA POPULATION
CHAPTER 3 DIABETES MELLITUS, OBESITY, HYPERTENSION AND DYSLIPIDEMIA IN ADULT CENTRAL KERALA POPULATION 3.1 BACKGROUND Diabetes mellitus (DM) and impaired glucose tolerance (IGT) have reached epidemic proportions
More informationNew Antihypertensive Strategies to Improve Blood Pressure Control
New Antihypertensive Strategies to Improve Blood Pressure Control Antonio Coca, MD, PhD,, FRCP, FESC Hypertension and Vascular Risk Unit Department of Internal Medicine. Hospital Clínic (IDIBAPS) University
More informationPredicting failure to follow-up screened high blood pressure in Japan: a cohort study
Journal of Public Health Vol. 37, No. 3, pp. 498 505 doi:10.1093/pubmed/fdu056 Advance Access Publication August 7, 2014 Predicting failure to follow-up screened high blood pressure in Japan: a cohort
More informationTracking of blood pressure in children and adolescents in Germany in the context of risk factors for hypertension
Tracking of blood pressure in children and adolescents in Germany in the context of risk factors for hypertension G. Sarganas, A. Schaffrath Rosario, C. Albrecht, A. Woll, H. Neuhauser Study population
More informationMetabolic Syndrome and Workplace Outcome
Metabolic Syndrome and Workplace Outcome Maine Worksite Wellness Initiative June 15, 2010 Alyssa B. Schultz Dee W. Edington Current Definition* of Metabolic Syndrome At least 3 of the following: Waist
More informationTalking about blood pressure
Talking about blood pressure Mrs Khan 56 BP 158/99 BMI 32 Total cholesterol 5.4 (HDL 0.8) HbA1c 43 She has been promising to do more exercise and eat more healthily for the last 2 years but her weight
More informationBiostats Final Project Fall 2002 Dr. Chang Claire Pothier, Michael O'Connor, Carrie Longano, Jodi Zimmerman - CSU
Biostats Final Project Fall 2002 Dr. Chang Claire Pothier, Michael O'Connor, Carrie Longano, Jodi Zimmerman - CSU Prevalence and Probability of Diabetes in Patients Referred for Stress Testing in Northeast
More informationHypertension Compendium
Hypertension Compendium Circulation Research Compendium on Hypertension The Epidemiology of Blood Pressure and Its Worldwide Management Genetic and Molecular Aspects of Hypertension Hypertension: Renin
More informationCARDIOVASCULAR RISK FACTORS & TARGET ORGAN DAMAGE IN GREEK HYPERTENSIVES
CARDIOVASCULAR RISK FACTORS & TARGET ORGAN DAMAGE IN GREEK HYPERTENSIVES C. Liakos, 1 G. Vyssoulis, 1 E. Karpanou, 2 S-M. Kyvelou, 1 V. Tzamou, 1 A. Michaelides, 1 A. Triantafyllou, 1 P. Spanos, 1 C. Stefanadis
More informationCurrent status on other health effects:
Current status on other health effects: Changes in Cardiovascular Risk Factors after the Great East Japan Earthquake Tetsuya Ohira, MD, PhD. Department of Epidemiology, Fukushima Medical University School
More informationDISCLOSURES OUTLINE OUTLINE 9/29/2014 ANTI-HYPERTENSIVE MANAGEMENT OF CHRONIC KIDNEY DISEASE
ANTI-HYPERTENSIVE MANAGEMENT OF CHRONIC KIDNEY DISEASE DISCLOSURES Editor-in-Chief- Nephrology- UpToDate- (Wolters Klewer) Richard J. Glassock, MD, MACP Geffen School of Medicine at UCLA 1 st Annual Internal
More informationGenetic bottlenecks, perceived racism, and hypertension risk among African Americans and first-generation African immigrants
(2001) 15, 341 351 2001 Nature Publishing Group All rights reserved 0950-9240/01 $15.00 www.nature.com/jhh ORIGINAL ARTICLE Genetic bottlenecks, perceived racism, and hypertension risk among African Americans
More informationORIGINAL INVESTIGATION. C-Reactive Protein Concentration and Incident Hypertension in Young Adults
ORIGINAL INVESTIGATION C-Reactive Protein Concentration and Incident Hypertension in Young Adults The CARDIA Study Susan G. Lakoski, MD, MS; David M. Herrington, MD, MHS; David M. Siscovick, MD, MPH; Stephen
More informationSupplement materials:
Supplement materials: Table S1: ICD-9 codes used to define prevalent comorbid conditions and incident conditions Comorbid condition ICD-9 code Hypertension 401-405 Diabetes mellitus 250.x Myocardial infarction
More informationImplications of Drug-related Increases in Blood Pressure
Implications of Drug-related Increases in Blood Pressure Preston M. Dunnmon, MD, FACP, FACC Division of Cardiovascular and Renal Products US Food and Drug Administration July 18, 2012 Disclaimer The findings
More informationManaging hypertension: a question of STRATHE
(2005) 19, S3 S7 & 2005 Nature Publishing Group All rights reserved 0950-9240/05 $30.00 www.nature.com/jhh ORIGINAL ARTICLE Managing hypertension: a question of STRATHE Department of Cardiovascular Disease,
More informationVal-MARC: Valsartan-Managing Blood Pressure Aggressively and Evaluating Reductions in hs-crp
Página 1 de 5 Return to Medscape coverage of: American Society of Hypertension 21st Annual Scientific Meeting and Exposition Val-MARC: Valsartan-Managing Blood Pressure Aggressively and Evaluating Reductions
More informationClinical Updates in the Treatment of Hypertension JNC 7 vs. JNC 8. Lauren Thomas, PharmD PGY1 Pharmacy Practice Resident South Pointe Hospital
Clinical Updates in the Treatment of Hypertension JNC 7 vs. JNC 8 Lauren Thomas, PharmD PGY1 Pharmacy Practice Resident South Pointe Hospital Objectives Review the Eighth Joint National Committee (JNC
More informationHypertension JNC 8 (2014)
Hypertension JNC 8 (2014) Renewed: February 2018 Updated: February 2015 Comparison of Seventh Joint National Committee (JNC 7) vs. Eighth Joint National Committee (JNC 8) Hypertension Guidelines Methodology
More informationPopulation: All participants Number of Obs: Variable # Sas Name: Sas Label: Categories: Variable # Sas Name: F80VNUM. Sas Label: Categories:
Form - Last Update: 04/6/001 umber of Obs: 161771 Participant ID 1 ID Participant ID F Days since randomization/enrollment 161771-886 8-59451 516548 FDAYS F Days since randomization/enrollment F Visit
More informationRiboflavin to lower blood pressure, a targeted nutrition approach
Riboflavin to lower blood pressure, a targeted nutrition approach Mary Ward RD, PhD Northern Ireland Centre for Food & Health (NICHE) / The Nutrition Society (UK) ulster.ac.uk Outline Background: Hypertension
More informationTreating Heart Failure in Biodiverse Patient Populations: Best Practices and Unveiling Disparities in Blacks
Treating Heart Failure in Biodiverse Patient Populations: Best Practices and Unveiling Disparities in Blacks 12th Annual Leadership Summit on Health Disparities & Congressional Black Caucus Spring Health
More informationKnow Your Number Aggregate Report Single Analysis Compared to National Averages
Know Your Number Aggregate Report Single Analysis Compared to National s Client: Study Population: 2242 Population: 3,000 Date Range: 04/20/07-08/08/07 Version of Report: V6.2 Page 2 Study Population Demographics
More informationSupplementary Online Content
Supplementary Online Content Xu X, Qin X, Li Y, et al. Efficacy of folic acid therapy on the progression of chronic kidney disease: the Renal Substudy of the China Stroke Primary Prevention Trial. JAMA
More information